ABBOTT IRELAND ARCHITECT HBSAG QUALITATIVE II CONFIRMATORY REAGENT KIT; TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM)
|
Back to Search Results |
|
Catalog Number 02G23-25 |
Device Problem
False Positive Result (1227)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 09/02/2022 |
Event Type
malfunction
|
Manufacturer Narrative
|
This report is being filed on an international product, list number 02g23 that has a similar product distributed in the us, list number 04p54.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
|
|
Event Description
|
The customer observed false positive architect hbsag qualitative ii confirmatory result for one patient.The customer had some imprecision issue with this assay and therefore decided to repeat the confirmatory testing.The repeated confirmatory result was negative.The following data was provided: sid (b)(6) hbsag initial result = 2.14 s/co (reactive), repeat results = 1.10 s/co (reactive), 1.04 s/co (reactive).Initial hbsag confirmatory result: hbsag %n = 76%, hbsag c2 result = 3.97 s/co (positive) repeat hbsag confirmatory result: hbsag %n =15%, hbsag c2 result = 1.33 s/co (negative) additional lab results provided: anti- hbc = nonreactive the customer believed the negative hbsag confirmatory is the correct result.No impact to patient management was reported.
|
|
Manufacturer Narrative
|
The complaint investigation false reactive architect hbsag quantitative ii confirmatory result included a review of data and information provided by the customer, search for similar complaints, ticket trending review, device history record review, and labeling review.In-house testing of retained reagent kit was also completed.Return testing was not completed as returns were not available.Data and information provided by the customer were reviewed and support the complaint issue.Ticket search by lot indicates that the reagent lot performs as expected for this product.Trending review did not identify any trends for the issue for the product.Device history record review did not identify any non-conformances or deviations with lot number 34477fn00 and complaint issue.Labeling was reviewed and sufficiently addresses the customer's issue.In-house testing of a retained reagent kit of the complaint lot 34477fn00 was performed.All specifications were met which indicates the lot is performing acceptably.In this case, sample integrity issues or a preanalytical error with the initial testing could have contributed to the customer¿s observation.Per product labeling, if the architect hbsag qualitative ii confirmatory results are inconsistent with clinical evidence, additional testing is suggested to confirm the result.For diagnostic purposes, results should be used in conjunction with patient history and other hepatitis markers for diagnosis of acute and chronic infection.Based on this investigation, no systemic issue or deficiency with the architect hbsag quantitative ii confirmatory reagent, lot number 34477fn00 was identified.
|
|
Search Alerts/Recalls
|
|
|